UnitedHealth Competitors

Stocks . Brazil . 
Stock . UnitedHealth Group Incorporated
UNHH34 Stock   49.49  2.02  4.26%   
UnitedHealth Group competes with Qualicorp Consultoria, Fras Le, Western Digital, and BTG Pactual; as well as few others. The company operates under Healthcare sector and is part of Healthcare Plans industry. Analyzing UnitedHealth Group competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of UnitedHealth Group to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out UnitedHealth Group Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of UnitedHealth Group competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
47.7049.4951.28
Details
Intrinsic
Valuation
LowRealHigh
39.1240.9154.44
Details
Naive
Forecast
LowNextHigh
48.0649.8651.65
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
44.3447.8851.43
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as UnitedHealth Group. Your research has to be compared to or analyzed against UnitedHealth Group's peers to derive any actionable benefits. When done correctly, UnitedHealth Group's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in UnitedHealth Group.

UnitedHealth Group Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between UnitedHealth Group and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of UnitedHealth and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of UnitedHealth Group does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
RAPT3
+ 0.89
E1RI34
RAPT3
+ 0.62
C1AB34
RAPT3
+ 0.58
FRAS3
DASA3
+ 0.58
BTLG11
E1RI34
+ 0.57
FRAS3
C1AB34
+ 0.54
W1DC34
  
High negative correlations   
E1RI34
- 0.79
BTLG11
DASA3
- 0.73
C1AB34
RAPT3
- 0.72
BTLG11
DASA3
- 0.66
E1RI34
DASA3
- 0.62
W1DC34
DASA3
- 0.6
RAPT3

Risk-Adjusted Indicators

There is a big difference between UnitedHealth Stock performing well and UnitedHealth Group Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze UnitedHealth Group's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
UNHH34  1.27  0.16  0.02 (0.52) 1.77 
(1.27)
 2.51 
(2.43)
 9.46 
QUAL3  3.64  0.34  0.03 (0.52) 4.81 
(4.39)
 10.39 
(6.73)
 32.65 
FRAS3  1.02  0.12  0.00 (0.86) 1.17 
(1.14)
 2.61 
(1.71)
 8.74 
W1DC34  0.35  0.12  0.00 (0.41) 0.00 
 0.00 
 0.00 
 0.00 
 9.38 
CLIN11  0.66 (0.05) 0.00  0.55  0.00 
 0.00 
 1.01 
(1.58)
 4.19 
BTLG11  0.51 (0.07) 0.00  0.69  0.00 
 0.00 
 0.98 
(1.20)
 4.73 
E1RI34  1.23  0.25  0.09 (1.27) 0.90 
(2.15)
 3.48 
(2.09)
 16.05 
C1AB34  1.41  0.30  0.08  2.35  1.33 
(2.42)
 4.35 
(2.60)
 14.25 
RAPT3  1.17  0.03 (0.06)(0.09) 1.43 
(1.29)
 2.29 
(2.47)
 9.30 
DASA3  2.20 (0.58) 0.00 (84.44) 0.00 
 0.00 
 3.68 
(4.53)
 14.36 
All Fundamental Data

UnitedHealth Group Competitive Analysis

The better you understand UnitedHealth Group competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, UnitedHealth Group's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across UnitedHealth Group's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
UNHH34 QUAL3 FRAS3 W1DC34 CLIN11 BTLG11 E1RI34 C1AB34 RAPT3 DASA3
 4.26 
 49.49 
UnitedHealth
 8.64 
 2.22 
Qualicorp
 2.87 
 20.00 
Fras
 0.00 
 365.00 
Western
 0.79 
 88.66 
Clave
 0.72 
 97.30 
BTG
 2.48 
 23.16 
Telefonaktiebolaget
 1.73 
 11.73 
Cable
 1.20 
 9.05 
Randon
 2.61 
 2.24 
Diagnsticos
Market Volatility
(90 Days Market Risk)
Very steady
Dangerous
Very steady
Very steady
Very steady
Very steady
Not too volatile
Not too volatile
Not too volatile
Risky
Market Performance
(90 Days Performance)
Modest
Insignificant
Insignificant
OK
Very Weak
Very Weak
OK
Good
Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Below Average
Low
Below Average
Unknown
Low
Low
Low
Low
Quite High
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Buy
Strong Sell
Strong Sell
Current Ratio
N/A
1.58
1.98
2.01
2.78
N/A
1.86
2.25
1.58
Net Asset
245.71 B
4.4 B
3.08 B
26.26 B
N/A
305.61 B
6.95 B
10.72 B
23.25 B
Profit Margin
0.0621
0.11
0.064
-0.0059
18.96
0.069
0.22
0.0494
-0.0271
EBITDA
31.84 B
997.02 M
421.55 M
3.32 B
N/A
38.66 B
789.6 M
1.3 B
1.07 B
Operating Margin
0.0877
0.27
0.11
0.0554
62.59
N/A
0.31
0.11
0.0623
Current Valuation
2.7 T
2.86 B
1.93 B
85.55 B
202.43 M
101.24 B
41.25 B
5.74 B
17.24 B
Price To Book
6.68
1.02
1.54
0.91
1.08
1.46
2.3
0.95
1.0
Retained Earnings
N/A
352 M
130 M
N/A
N/A
N/A
N/A
341 M
N/A
Current Asset
N/A
977 M
474 M
N/A
N/A
N/A
N/A
2.91 B
N/A
Five Year Return
N/A
5.02
3.77
N/A
N/A
N/A
N/A
N/A
0.68
Beta
0.69
0.76
0.77
1.65
0.65
0.27
0.81
1.1
0.25
Number Of Employees
10
2.82 K
5 K
65 K
N/A
105.53 K
3.63 K
16.13 K
24
Shares Outstanding
65.4 B
278.45 M
267.02 M
319.33 M
1.65 M
6.66 B
1.16 B
116.52 M
557.11 M
Cash Flow From Operations
26.21 B
807.93 M
245.04 M
1.88 B
5.63 M
39.06 B
704.34 M
909.06 M
1.3 B
Annual Yield
0.0129
0.0471
0.0341
0.0258
N/A
0.0457
0.0136
0.11
0.0098
Total Debt
54.51 B
306.42 M
923.67 M
7.02 B
N/A
22.24 B
3.8 B
3.06 B
6.97 B
Return On Equity
0.25
0.15
0.13
-0.0077
1.13
0.16
0.21
0.2
-0.0458
Z Score
27.4
2.4
1.2
6.0
N/A
2.4
3.6
N/A
N/A
Return On Asset
0.0776
0.0722
0.0597
0.0213
2.33
0.0592
0.0472
0.0669
0.0224
Book Value Per Share
2.49
5.2
6.74
37.98
98.81
N/A
325.52
8.44
13.13
Current Liabilities
N/A
1.13 B
236 M
N/A
N/A
N/A
N/A
1.13 B
N/A
Total Asset
245.71 B
4.4 B
3.08 B
26.26 B
N/A
305.61 B
6.95 B
10.72 B
23.25 B
Last Dividend Paid
6.4
0.26
0.28
N/A
0.32
N/A
11.1
0.73
0.3
Debt To Equity
N/A
1.86
50.7
0.93
N/A
N/A
2.38
131.7
97.7
Target Price
N/A
8.15
13.8
N/A
N/A
N/A
N/A
N/A
19.83
Shares Owned By Institutions
N/A
61.11
33.16
N/A
0.03
N/A
N/A
14.68
33.62
Market Capitalization
2.42 T
1.43 B
2.73 B
72.69 B
157.42 M
101.28 B
24.75 B
2.58 B
5.51 B
Price To Earnings To Growth
1.64
1.67
N/A
490.96
N/A
1.89
N/A
N/A
N/A
Price To Earning
N/A
4.22
17.57
53.91
98.94
N/A
0.19
20.64
63.21
Price To Sales
8.35
0.72
0.91
3.41
14.75
0.79
13.89
0.24
0.57
Net Income
20.12 B
365.81 M
211.23 M
1.5 B
2.02 M
22.69 B
291.82 M
697.88 M
(226.57 M)
Earnings Per Share
1.58
0.8
0.76
15.83
1.08
1.44
1.56
1.91
-0.3
Shares Owned By Insiders
N/A
26.19
65.61
N/A
N/A
N/A
N/A
81.71
56.27
Revenue
322.13 B
2.1 B
2.58 B
18.79 B
10.67 M
232.31 B
1.61 B
9.06 B
10.42 B
Working Capital
N/A
(150 M)
238 M
N/A
N/A
N/A
N/A
1.78 B
N/A
Cash And Equivalents
N/A
449.44 M
236.68 M
2.73 B
N/A
N/A
448.96 M
1.76 B
832.69 M
Cash Per Share
N/A
3.92
0.57
8.92
N/A
N/A
74.36
4.07
1.76
Gross Profit
79.62 B
1.67 B
748.3 M
5.87 B
8.26 M
113.49 B
1.15 B
2.27 B
3.12 B
Day Typical Price
49.59
2.28
20.14
365.0
89.01
97.27
23.1
11.72
9.09
2.25
Accumulation Distribution
0.0237
0.0988
0.0297
N/A
0.0208
0.0133
0.0078
0.0093
0.0131
0.0435
Market Facilitation Index
1.19
0.24
0.61
N/A
1.87
1.3
0.18
0.11
0.12
0.1
Daily Balance Of Power
1.697479
(0.88)
(0.97)
0.0
(0.38)
0.5385
(3.28)
1.818182
(0.92)
(0.60)
Period Momentum Indicator
2.02
(0.21)
(0.59)
N/A
(0.71)
0.7
(0.59)
0.2
(0.11)
(0.06)
Rate Of Daily Change
1.04
0.91
0.97
1.0
0.99
1.01
0.98
1.02
0.99
0.97
Day Median Price
49.65
2.31
20.2
365.0
89.19
97.25
23.07
11.72
9.11
2.25
Price Action Indicator
0.86
(0.19)
(0.50)
N/A
(0.88)
0.4
(0.21)
0.12
(0.11)
(0.04)
Relative Strength Index
55.46
49.75
40.25
53.78
41.3
46.8
53.53
70.76
48.24
33.21
Coefficient Of Variation
1189.67
1844.05
1258.76
1004.83
(1,549)
(1,036)
905.99
684.87
5997.16
(498.60)
Mean Deviation
1.27
3.64
1.02
0.3488
0.6599
0.5101
1.23
1.41
1.17
2.2
Jensen Alpha
0.1636
0.343
0.1155
0.1233
(0.05)
(0.07)
0.2472
0.3029
0.0345
(0.58)
Total Risk Alpha
(0.09)
(0.43)
(0.08)
(0.04)
(0.18)
(0.18)
(0.05)
0.0248
(0.19)
(0.95)
Sortino Ratio
0.0192
0.0334
0.0031
N/A
N/A
N/A
0.0883
0.0842
(0.06)
N/A
Downside Variance
3.88
31.84
1.69
N/A
N/A
N/A
2.16
6.62
2.21
N/A
Standard Deviation
1.75
5.49
1.43
1.1
0.853
0.7279
2.17
2.23
1.57
2.86
Kurtosis
3.28
2.53
2.36
20.82
0.128
2.68
19.73
3.88
1.5
0.7101
Potential Upside
2.51
10.39
2.61
N/A
1.01
0.9777
3.48
4.35
2.29
3.68
Treynor Ratio
(0.52)
(0.52)
(0.86)
(0.41)
0.5527
0.6866
(1.27)
2.35
(0.09)
(84.44)
Maximum Drawdown
9.46
32.65
8.74
9.38
4.19
4.73
16.05
14.25
9.3
14.36
Variance
3.07
30.14
2.04
1.2
0.7276
0.5298
4.7
4.99
2.46
8.15
Market Risk Adjusted Performance
(0.51)
(0.51)
(0.85)
(0.40)
0.5627
0.6966
(1.26)
2.36
(0.08)
(84.43)
Risk Adjusted Performance
0.0698
0.05
0.0653
0.079
(0.05)
(0.07)
0.0907
0.118
0.0179
(0.15)
Skewness
(0.83)
0.2227
0.6318
3.45
(0.24)
0.4909
3.58
0.9668
0.4033
(0.14)
Semi Deviation
1.77
4.81
1.17
N/A
N/A
N/A
0.9017
1.33
1.43
N/A
Information Ratio
0.0216
0.0343
0.0028
(0.0002)
(0.19)
(0.25)
0.0599
0.097
(0.05)
(0.24)
Value At Risk
(2.43)
(6.73)
(1.71)
N/A
(1.58)
(1.20)
(2.09)
(2.60)
(2.47)
(4.53)
Expected Short fall
(1.27)
(4.39)
(1.14)
N/A
N/A
N/A
(2.15)
(2.42)
(1.29)
N/A
Downside Deviation
1.97
5.64
1.3
N/A
N/A
N/A
1.47
2.57
1.49
N/A
Semi Variance
3.13
23.11
1.37
N/A
N/A
N/A
0.8131
1.78
2.05
N/A

UnitedHealth Group Competition Performance Charts

Five steps to successful analysis of UnitedHealth Group Competition

UnitedHealth Group's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by UnitedHealth Group in relation to its competition. UnitedHealth Group's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of UnitedHealth Group in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact UnitedHealth Group's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to UnitedHealth Group, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your UnitedHealth Group position

In addition to having UnitedHealth Group in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Petroleum and Natural Gas Thematic Idea Now

Petroleum and Natural Gas
Petroleum and Natural Gas Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Petroleum and Natural Gas theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Petroleum and Natural Gas Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in UnitedHealth Stock

When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:
How To Invest In UnitedHealth
Details
Is UnitedHealth Stock a good investment?
Details
What is UnitedHealth Group's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out UnitedHealth Group Correlation with its peers.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY